Invero Pharma Inc. and Rheos Medical Corporation Collaborate to Improve Survival Post-Cardiac Arrest
Drug Developer Invero Pharma and Device Manufacturer Rheos work together to bring the orphan drug and FDA fast-track designated Xenex (xenon gas) into phase 3. BUFFALO, NEW YORK, USA, April 23, 2024 /EINPresswire.com/ -- Invero Pharma Inc. and Rheos …